A citation-based method for searching scientific literature

Carmen F A Eustatia-Rutten, Eleonora P M Corssmit, Nienke R Biermasz, Alberto M Pereira, Johannes A Romijn, Johannes W Smit. J Clin Endocrinol Metab 2006
Times Cited: 201







List of co-cited articles
635 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma.
Ying C Henderson, Thomas D Shellenberger, Michelle D Williams, Adel K El-Naggar, Mitchell J Fredrick, Kathleen M Cieply, Gary L Clayman. Clin Cancer Res 2009
92
3

Classification of papillary cancer of the thyroid based on prognosis.
S Noguchi, N Murakami, H Kawamoto. World J Surg 1994
79
3


Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas.
Adebowale J Adeniran, Zhaowen Zhu, Manoj Gandhi, David L Steward, James P Fidler, Thomas J Giordano, Paul W Biddinger, Yuri E Nikiforov. Am J Surg Pathol 2006
342
3

Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment.
Stéphane Bonnet, Dana Hartl, Sophie Leboulleux, Eric Baudin, Jean D Lumbroso, Abir Al Ghuzlan, Linda Chami, Martin Schlumberger, Jean Paul Travagli. J Clin Endocrinol Metab 2009
198
3


Gender is an age-specific effect modifier for papillary cancers of the thyroid gland.
Briseis A Kilfoy, Susan S Devesa, Mary H Ward, Yawei Zhang, Philip S Rosenberg, Theodore R Holford, William F Anderson. Cancer Epidemiol Biomarkers Prev 2009
137
3

Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia.
S L Sugg, S Ezzat, I B Rosen, J L Freeman, S L Asa. J Clin Endocrinol Metab 1998
226
3

Low-risk differentiated thyroid cancer and radioiodine remnant ablation: a systematic review of the literature.
Livia Lamartina, Cosimo Durante, Sebastiano Filetti, David S Cooper. J Clin Endocrinol Metab 2015
96
3


PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected].
T G Kroll, P Sarraf, L Pecciarini, C J Chen, E Mueller, B M Spiegelman, J A Fletcher. Science 2000
631
3

A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.
E L Mazzaferri, R J Robbins, C A Spencer, L E Braverman, F Pacini, L Wartofsky, B R Haugen, S I Sherman, D S Cooper, G D Braunstein,[...]. J Clin Endocrinol Metab 2003
425
3

Evaluating the prognostic factors associated with cancer-specific survival of differentiated thyroid carcinoma presenting with distant metastasis.
Brian Hung-Hin Lang, Kai Pun Wong, Chung Yeung Cheung, Koon Yat Wan, Chung-Yau Lo. Ann Surg Oncol 2013
67
4

Risk-adapted management of thyroid cancer.
R Michael Tuttle. Endocr Pract 2008
58
5

RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
Massimo Santoro, Rosa Marina Melillo, Alfredo Fusco. Eur J Endocrinol 2006
135
3

Measuring inconsistency in meta-analyses.
Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, Douglas G Altman. BMJ 2003
3

TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.
Xiaoli Liu, Shen Qu, Rengyun Liu, Chunjun Sheng, Xiaoguang Shi, Guangwu Zhu, Avaniyapuram Kannan Murugan, Haixia Guan, Hongyu Yu, Yangang Wang,[...]. J Clin Endocrinol Metab 2014
203
3

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
3

Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
Xiaoli Liu, Justin Bishop, Yuan Shan, Sara Pai, Dingxie Liu, Avaniyapuram Kannan Murugan, Hui Sun, Adel K El-Naggar, Mingzhao Xing. Endocr Relat Cancer 2013
398
3

Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion.
Vasily Vasko, Allan V Espinosa, William Scouten, Huiling He, Herbert Auer, Sandya Liyanarachchi, Alexander Larin, Victoria Savchenko, Gary L Francis, Albert de la Chapelle,[...]. Proc Natl Acad Sci U S A 2007
251
3

Consensus statement on the terminology and classification of central neck dissection for thyroid cancer.
Sally E Carty, David S Cooper, Gerard M Doherty, Quan-Yang Duh, Richard T Kloos, Susan J Mandel, Gregory W Randolph, Brendan C Stack, David L Steward, David J Terris,[...]. Thyroid 2009
364
3

Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period.
Ian D Hay, Maeve E Hutchinson, Tomas Gonzalez-Losada, Bryan McIver, Megan E Reinalda, Clive S Grant, Geoffrey B Thompson, Thomas J Sebo, John R Goellner. Surgery 2008
385
3

Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
David Hiltzik, Diane L Carlson, R Michael Tuttle, Shaokun Chuai, Nicole Ishill, Ashok Shaha, Jatin P Shah, Buvanesh Singh, Ronald A Ghossein. Cancer 2006
194
3

The impact of nodal status on outcome in older patients with papillary thyroid cancer.
Iain J Nixon, Laura Y Wang, Frank L Palmer, R Michael Tuttle, Ashok R Shaha, Jatin P Shah, Snehal G Patel, Ian Ganly. Surgery 2014
71
4

Treatment of advanced thyroid cancer with targeted therapies: ten years of experience.
David Viola, Laura Valerio, Eleonora Molinaro, Laura Agate, Valeria Bottici, Agnese Biagini, Loredana Lorusso, Virginia Cappagli, Letizia Pieruzzi, Carlotta Giani,[...]. Endocr Relat Cancer 2016
110
3

Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors.
Hong-Jun Song, Zhong-Ling Qiu, Chen-Tian Shen, Wei-Jun Wei, Quan-Yong Luo. Eur J Endocrinol 2015
66
4

International patterns and trends in thyroid cancer incidence, 1973-2002.
Briseis A Kilfoy, Tongzhang Zheng, Theodore R Holford, Xuesong Han, Mary H Ward, Andreas Sjodin, Yaqun Zhang, Yana Bai, Cairong Zhu, Grace L Guo,[...]. Cancer Causes Control 2009
471
3


Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
Michael Rivera, Ronald A Ghossein, Heiko Schoder, Daniel Gomez, Steven M Larson, R Michael Tuttle. Cancer 2008
130
3

The changing incidence of thyroid cancer.
Cari M Kitahara, Julie A Sosa. Nat Rev Endocrinol 2016
481
3

Thyroid cancer mortality and incidence: a global overview.
Carlo La Vecchia, Matteo Malvezzi, Cristina Bosetti, Werner Garavello, Paola Bertuccio, Fabio Levi, Eva Negri. Int J Cancer 2015
580
3

Principles of cancer therapy: oncogene and non-oncogene addiction.
Ji Luo, Nicole L Solimini, Stephen J Elledge. Cell 2009
3

Identification of novel cancer therapeutic targets using a designed and pooled shRNA library screen.
David Oliver, Hao Ji, Piaomu Liu, Alexander Gasparian, Ellen Gardiner, Samuel Lee, Adrian Zenteno, Lillian O Perinskaya, Mengqian Chen, Phillip Buckhaults,[...]. Sci Rep 2017
27
11

Identification of thyroid tumor cell vulnerabilities through a siRNA-based functional screening.
Maria Anania, Fabio Gasparri, Elena Cetti, Ivan Fraietta, Katia Todoerti, Claudia Miranda, Mara Mazzoni, Claudia Re, Riccardo Colombo, Giorgio Ukmar,[...]. Oncotarget 2015
20
15

COPI complex is a regulator of lipid homeostasis.
Mathias Beller, Carole Sztalryd, Noel Southall, Ming Bell, Herbert Jäckle, Douglas S Auld, Brian Oliver. PLoS Biol 2008
250
3

Early endosomes and endosomal coatomer are required for autophagy.
Minoo Razi, Edmond Y W Chan, Sharon A Tooze. J Cell Biol 2009
205
3

Knockdown of COPA, identified by loss-of-function screen, induces apoptosis and suppresses tumor growth in mesothelioma mouse model.
Hitomi Sudo, Atsushi B Tsuji, Aya Sugyo, Masakazu Kohda, Chizuru Sogawa, Chisato Yoshida, Yoshi-nobu Harada, Okio Hino, Tsuneo Saga. Genomics 2010
52
5

Tumor-specific silencing of COPZ2 gene encoding coatomer protein complex subunit ζ 2 renders tumor cells dependent on its paralogous gene COPZ1.
Michael Shtutman, Mirza Baig, Elina Levina, Gregory Hurteau, Chang-Uk Lim, Eugenia Broude, Mikhail Nikiforov, Timothy T Harkins, C Steven Carmack, Ye Ding,[...]. Proc Natl Acad Sci U S A 2011
33
9

IGFBP7: an oncosuppressor gene in thyroid carcinogenesis.
M G Vizioli, M Sensi, C Miranda, L Cleris, F Formelli, M C Anania, M A Pierotti, A Greco. Oncogene 2010
65
4

The COPI system: molecular mechanisms and function.
R Beck, M Rawet, F T Wieland, D Cassel. FEBS Lett 2009
186
3

Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer.
Hyun Seok Kim, Saurabh Mendiratta, Jiyeon Kim, Chad Victor Pecot, Jill E Larsen, Iryna Zubovych, Bo Yeun Seo, Jimi Kim, Banu Eskiocak, Hannah Chung,[...]. Cell 2013
129
3

Papillary thyroid carcinomas with lung metastases.
Jen-Der Lin, Tzu-Chieh Chao, Shuo-Chi Chou, Chuen Hsueh. Thyroid 2004
41
7


Association between screening and the thyroid cancer "epidemic" in South Korea: evidence from a nationwide study.
Sohee Park, Chang-Mo Oh, Hyunsoon Cho, Joo Young Lee, Kyu-Won Jung, Jae Kwan Jun, Young-Joo Won, Hyun-Joo Kong, Kui Son Choi, You Jin Lee,[...]. BMJ 2016
138
3

Both exogenous subclinical hyperthyroidism and short-term overt hypothyroidism affect myocardial strain in patients with differentiated thyroid carcinoma.
Randa M Abdulrahman, Victoria Delgado, Hendrieke C Hoftijzer, Arnold C T Ng, See Hooi Ewe, Nina Ajmone Marsan, Eduard R Holman, Guido C Hovens, Eleonora P Corssmit, Johannes A Romijn,[...]. Thyroid 2011
31
9

Prevalence of atrial fibrillation in patients taking TSH suppression therapy for management of thyroid cancer.
Abdulgani Abonowara, Ata Quraishi, John L Sapp, Mohammed H Alqambar, Adi Saric, Colleen M O'Connell, Murali M Rajaraman, Robert D Hart, Syed A Imran. Clin Invest Med 2012
38
7

Extent of surgery affects survival for papillary thyroid cancer.
Karl Y Bilimoria, David J Bentrem, Clifford Y Ko, Andrew K Stewart, David P Winchester, Mark S Talamonti, Cord Sturgeon. Ann Surg 2007
431
3

Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer.
Mohamed Abdelgadir Adam, John Pura, Paolo Goffredo, Michaela A Dinan, Shelby D Reed, Randall P Scheri, Terry Hyslop, Sanziana A Roman, Julie A Sosa. J Clin Oncol 2015
199
3

Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers.
Seong-Keun Yoo, Seungbok Lee, Su-Jin Kim, Hyeon-Gun Jee, Byoung-Ae Kim, Hyesun Cho, Young Shin Song, Sun Wook Cho, Jae-Kyung Won, Jong-Yeon Shin,[...]. PLoS Genet 2016
182
3

Long-term cardiovascular morbidity and mortality in patients treated for differentiated thyroid cancer.
Nelli Pajamäki, Saara Metso, Tommi Hakala, Tapani Ebeling, Heini Huhtala, Essi Ryödi, Juhani Sand, Arja Jukkola-Vuorinen, Pirkko-Liisa Kellokumpu-Lehtinen, Pia Jaatinen. Clin Endocrinol (Oxf) 2018
30
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.